<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="60557">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02118935</url>
  </required_header>
  <id_info>
    <org_study_id>6023</org_study_id>
    <nct_id>NCT02118935</nct_id>
  </id_info>
  <brief_title>Nutritive Effects of Prebiotics on Early Postnatal Behavioral Measures of Tolerance</brief_title>
  <official_title>Nutritive Effects of Prebiotics on Early Postnatal Behavioral Measures of Tolerance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mead Johnson Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Kansas</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mead Johnson Nutrition</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is intended to measure infant comfort, behavior, and sleep when consuming study
      formula with prebiotics compared to infants who consume a study formula without the
      prebiotics.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator)</study_design>
  <primary_outcome>
    <measure>Sleep Measures (Amount of time awake and asleep in a 72 hour period)</measure>
    <time_frame>14 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Infant State (Infant behavior over a 72 hour period)</measure>
    <time_frame>14 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Achieved Weight</measure>
    <time_frame>14 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Total weight gain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Achieved Length</measure>
    <time_frame>14 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Total length gain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Achieved Head Circumference</measure>
    <time_frame>14 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Total head circumference gain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Formula Intake</measure>
    <time_frame>14 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal microbiome</measure>
    <time_frame>Baseline and 112 days of age</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medically-confirmed Adverse Events</measure>
    <time_frame>14 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Salivary Cortisol levels</measure>
    <time_frame>70 and 120 days of age</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Temperament - Infant Behavior Questionnaire</measure>
    <time_frame>Once at 112 days of age</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Characteristics</measure>
    <time_frame>14 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Amount of waking and sleeping, number of waking and sleep episodes</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">153</enrollment>
  <condition>Behavioral Measures of Tolerance</condition>
  <arm_group>
    <arm_group_label>Previously marketed cow's milk-based infant formula</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Marketed cow's milk-based infant formula with prebiotics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Previously marketed cow's mlik-based infant formula</intervention_name>
    <arm_group_label>Previously marketed cow's milk-based infant formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Marketed cow's milk-based infant formula with prebiotics</intervention_name>
    <arm_group_label>Marketed cow's milk-based infant formula with prebiotics</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Singleton, 14-35 days of age at baseline

          -  Term infant with birth weight of a minimum of 2500 grams

          -  Solely formula-fed

          -  Signed Informed Consent and Protected Health Information authorization

        Exclusion Criteria:

          -  History of underlying metabolic or chronic disease, congenital malformation, or
             immunocompromised

          -  Feeding difficulties or formula intolerance

          -  Maternal history of illicit drug use or psychiatric disease
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>35 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carol Lynn Berseth, MD</last_name>
    <role>Study Director</role>
    <affiliation>Mead Johnson Nutrition</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ashlee Kirchoff, BS</last_name>
    <phone>82-429-7997</phone>
    <email>ashlee.kirchoff@mjn.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universty of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Carlson, Ph.D.</last_name>
    </contact>
    <investigator>
      <last_name>Susan Carlson, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Colombo, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 18, 2014</lastchanged_date>
  <firstreceived_date>April 4, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
